Attending this event?
Wednesday, March 11 • 9:15am - 10:00am
Chorus: A Model to Externally Fund the Development of Deprioritized Assets From R&D to PoC

Sign up or log in to save this to your schedule and see who's attending!

  • Examine how Chorus, an autonomous R&D unit within Eli Lilly, functions as a lean approach to develop, de-risk and increase the value of early phase assets
  • Explore how this model aligns with Lilly’s capital fund strategy and works with outside venture capital to continue programs outside of Lilly’s core focus areas
  • Hear case examples and success stories since Chorus’ inception

avatar for Linus S Lin, Ph.D.

Linus S Lin, Ph.D.

Managing Director, Chorus, ELI LILLY

Wednesday March 11, 2020 9:15am - 10:00am